|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net Income | |||||
| Net Income | |||||
| Operating Activities | |||||
| Depreciation and amortization | |||||
| Amortization of deferred financing costs | |||||
| Deferred income taxes | |||||
| Goodwill, Impairment Loss | |||||
| Restructuring Charges | |||||
| Impairment of Long-Lived Assets Held-for-use | |||||
| Stock-based compensation | |||||
| Dividends from unconsolidated affiliates | |||||
| Other non-current liabilities | |||||
| Other | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing Activities | |||||
| Expenditures for property, plant and equipment | |||||
| Purchase of noncontrolling interest | |||||
| Business acquisitions, net of cash acquired | |||||
| Proceeds from sale of assets | |||||
| Proceeds from Sales of Business, Affiliate and Productive Assets | |||||
| Proceeds from Sale of Debt Securities, Available-for-sale | |||||
| Net cash used for investing activities | |||||
| Financing Activities | |||||
| Additions to long-term debt | |||||
| Reductions of long-term debt | |||||
| Net additions (reductions) to revolving credit agreements | |||||
| Cash dividends paid | |||||
| Payments of Ordinary Dividends, Noncontrolling Interest | |||||
| Financing fees paid | |||||
| Payments for Repurchase of Common Stock | |||||
| Other financing activities | |||||
| Net cash provided by (used for) financing activities | |||||
| Cash and Cash Equivalents | |||||
| Increase (decrease) for the year | |||||
| Balance at the beginning of the year | |||||
| Balance at the end of the year | |||||
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | |||||
Loading...